期刊文献+

他汀类药物在糖尿病患者心血管事件一级预防中的新证据和新指南 被引量:7

原文传递
导出
摘要 大量的循证医学证据证实了他汀类药物的心血管事件二级预防作用。但是,他汀类药物在心血管事件一级预防中患者是否获益目前仍有争论。糖尿病本身是冠心病的等危症,无心血管疾病的糖尿病患者使用他汀类药物进行心血管事件一级预防应视为非糖尿病患者的二级预防。如此推论,糖尿病患者使用他汀类药物进行心血管事件一级预防应该获得肯定。临床真实情况是否如此?近期陆续发表的一些研究,用部分临床研究证据对其进行了初步的分析和探索。
作者 郑刚
出处 《中华临床医师杂志(电子版)》 CAS 2013年第1期125-127,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献11

  • 1Xia Sheng,Michael J. Murphy,Thomas M. MacDonald,Li Wei.Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study[J].European Journal of Clinical Pharmacology.2012(8)
  • 2KNOPP R H,D’’EMDEN M,SMILDE J G,et al.Efficacyand safety of atorvastatin in the prevention of cardiovascularend points in subjects with type 2 diabetes:the AtorvastatinStudy for Prevention of Coronary Heart Disease Endpoints innon-insulin-dependent diabetes mellitus(ASPEN)[].Diabetes Care.2006
  • 3C Wanner,V Krane,W Marz,M Olschewski,HG Asmus,W Kramer.Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics[].Kidney Blood Press Res.2004
  • 4European Association for Cardiovascular Prevention & Rehabilitation,Reiner Z,Catapano AL,et al.ESC/EAS Guidelines for the management of dyslipidaemias ? The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)[].European Heart Journal.2011
  • 5De Berardis G,Sacco M,Evangelista V,Filippi A,Giorda CB,Tognoni Get al.Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D):Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated wi[].Trials.2007
  • 6Athyros,V.G.,Mikhailidis,D.P.,Papageorgiou,A.A.,Bouloukos,V.I.,Pehlivanidis,A.N.,Symeonides,A.N.,Kakafika,A.I.,Daskalopulou,S.S.,Elisaf,M.Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study[].Platelets.2005
  • 7Naoko Tajima,Hideaki Kurata,Noriaki Nakaya,Kyoichi Mizuno,Yasuo Ohashi,Toshio Kushiro,Tamio Teramoto,Shinichiro Uchiyama,Haruo Nakamura.Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes:Diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (M[].Atherosclerosis.2008
  • 8American Diabetes Association.Standards of medical care in diabetes -2010[].Diabetes Care.2010
  • 9Chan KE,Thadhani R,Lazarus JM, et al.Modeling the 4D Study: Statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes[].Clin J Am Soc Nephrol.2010
  • 10Mrz W,Genser B,Drechsler C,et al.Atorvastatin and low-density lipoproteincholesterol in type 2 diabetes mellitus patients on hemodialysis[].Clin J AmSoc Nephrol.2011

同被引文献61

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部